IL17A and obesity due to melanocortin 4 receptor deficiency: For example, the fact that obesity has been reported with a better retention rate of IL-17-inhibitors might be explained by the IL-17-pathway since obesity has been shown to promote Th17 differentiation and IL-17 production45